ACRO BIOMEDICAL CO., LTD. (ACBM) › Shareholders' EquityACRO BIOMEDICAL CO., LTD. (ACBM) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2014: $3.9K2015: $28.6K2016: -$14.8K2017: $511.3K2018: $1.17M2019: $798.2K2020: $685.9K2021: $643.7K2022: $486.4K2023: -$257.0K2024: -$295.0K2025: -$387.0K-$387.0K2014Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$387.0K-31.2%2024-$295.0K-14.8%2023-$257.0K-152.8%2022$486.4K-24.4%2021$643.7K-6.1%2020$685.9K-14.1%2019$798.2K-31.6%2018$1.17M+128.4%2017$511.3K+3556.6%2016-$14.8K-151.7%2015$28.6K+629.6%2014$3.9K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share